3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NIH
13
INDUSTRY
5
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Breast Neoplasms
181
Lymphoma
97
Lymphoma, Large B-Cell, Diffuse
96
Precursor Cell Lymphoblastic Leukemia-Lymphoma
79
Sarcoma
69
Hodgkin Disease
54
Lymphoma, Non-Hodgkin
41
Triple Negative Breast Neoplasms
37
Burkitt Lymphoma
36
Lymphoma, Mantle-Cell
32
Leukemia
32
Lymphoma, Follicular
30
Multiple Myeloma
28
Carcinoma, Hepatocellular
28
Neoplasm Metastasis
23
Ovarian Neoplasms
21
Neoplasms
21
Lymphoma, Large-Cell, Anaplastic
18
Osteosarcoma
17
Lymphoma, B-Cell
17
Prostatic Neoplasms
16
Neuroblastoma
15
Lymphoma, T-Cell, Peripheral
15
Urinary Bladder Neoplasms
14
Recurrence
13
Lymphoma, Large-Cell, Immunoblastic
13
Inflammatory Breast Neoplasms
13
Immunoblastic Lymphadenopathy
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Stomach Neoplasms
10
Interventions
Cyclophosphamide
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Vincristine
2
Vaccines
2
Rituximab
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Papillomavirus Vaccines
2
Mass Screening
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Etoposide
2
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
2
pandemrix
1
lactitol
1
halofantrine
1
focetria
1
fludarabine
1
efineptakin alfa
1
efavirenz
1
X-Rays
1
VAP-cyclo protocol
1
Triage
1
Transplantation Conditioning
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Surveys and Questionnaires
1
Standard of Care
1
Spirometry
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
HIV Infections
×
Doxorubicin
×
Clear all
NCT00799136
2013-09-12
CATCH
Ontario Clinical Oncology Group (OCOG)
Phase 2
Completed
6 enrolled